A Bayesian prevalence-incidence mixture model for screening outcomes with misclassification
Authors:
Thomas Klausch,
Birgit I. Lissenberg-Witte,
Veerle M. Coupé
Abstract:
We present BayesPIM, a Bayesian prevalence-incidence mixture model for estimating time- and covariate-dependent disease incidence from screening and surveillance data. The method is particularly suited to settings where some individuals may have the disease at baseline, baseline tests may be missing or incomplete, and the screening test has imperfect test sensitivity. This setting was present in d…
▽ More
We present BayesPIM, a Bayesian prevalence-incidence mixture model for estimating time- and covariate-dependent disease incidence from screening and surveillance data. The method is particularly suited to settings where some individuals may have the disease at baseline, baseline tests may be missing or incomplete, and the screening test has imperfect test sensitivity. This setting was present in data from high-risk colorectal cancer (CRC) surveillance through colonoscopy, where adenomas, precursors of CRC, were already present at baseline and remained undetected due to imperfect test sensitivity. By including covariates, the model can quantify heterogeneity in disease risk, thereby informing personalized screening strategies. Internally, BayesPIM uses a Metropolis-within-Gibbs sampler with data augmentation and weakly informative priors on the incidence and prevalence model parameters. In simulations based on the real-world CRC surveillance data, we show that BayesPIM estimates model parameters without bias while handling latent prevalence and imperfect test sensitivity. However, informative priors on the test sensitivity are needed to stabilize estimation and mitigate non-convergence issues. We also show how conditioning incidence and prevalence estimates on covariates explains heterogeneity in adenoma risk and how model fit is assessed using information criteria and a non-parametric estimator.
△ Less
Submitted 10 March, 2025; v1 submitted 20 December, 2024;
originally announced December 2024.
A Bayesian accelerated failure time model for interval censored three-state screening outcomes
Authors:
Thomas Klausch,
Eddymurphy U. Akwiwu,
Mark A. van de Wiel,
Veerle M. H. Coupe,
Johannes Berkhof
Abstract:
Women infected by the Human papilloma virus are at an increased risk to develop cervical intraepithalial neoplasia lesions (CIN). CIN are classified into three grades of increasing severity (CIN-1, CIN-2, and CIN-3) and can eventually develop into cervical cancer. The main purpose of screening is detecting CIN-2 and CIN-3 cases which are usually surgically removed. Screening data from the POBASCAM…
▽ More
Women infected by the Human papilloma virus are at an increased risk to develop cervical intraepithalial neoplasia lesions (CIN). CIN are classified into three grades of increasing severity (CIN-1, CIN-2, and CIN-3) and can eventually develop into cervical cancer. The main purpose of screening is detecting CIN-2 and CIN-3 cases which are usually surgically removed. Screening data from the POBASCAM trial involving 1,454 HPV-positive women is analyzed with two objectives: estimate (a) the transition time from HPV diagnosis to CIN-3; and (b) the transition time from CIN-2 to CIN-3. The screening data have two key characteristics. First, the CIN state is monitored in an interval-censored sequence of screening times. Second, a woman's progression to CIN-3 is only observed, if the woman progresses to, both, CIN-2 and from CIN-2 to CIN-3 in the same screening interval. We propose a Bayesian accelerated failure time model for the two transition times in this three-state model. To deal with the unusual censoring structure of the screening data, we develop a Metropolis-within-Gibbs algorithm with data augmentation from the truncated transition time distributions.
△ Less
Submitted 3 December, 2021; v1 submitted 6 October, 2021;
originally announced October 2021.
